Gilmore O'Neill, M.B., M.M.Sc
Overview
Gilmore O'Neill, M.B., M.M.Sc received an average of $5M in total compensation, including $486K in salary, at Sarepta Therapeutics from 2018 to 2020.
Source: SEC filings on April 25, 2022, April 21, 2020, and April 26, 2019.
Related executives
We found 30 more executives who work or worked at Sarepta Therapeutics.
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
David Howton
Sarepta Therapeutics
General Counsel
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
Joseph Bratica
Sarepta Therapeutics